To evaluate the clinical significance of FOXD2-AS1 in cervical cancer, we subdivided all patients with cervical cancer into low- and high-FOXD2-AS1 groups based on a median level of FOXD2-AS1 expression and then investigated the association between FOXD2-AS1 and the clinical parameters of patients with cervical cancer. This evidence concerns the gene FOXD2 and cervical carcinoma.